4.0 Review

Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials

Publisher

ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.jogoh.2020.101798

Keywords

Endometriosis; Pain; Pharmacological interventions

Ask authors/readers for more resources

This study assessed and ranked different pharmacological interventions for relieving endometriosis-related pain, with CHCs, GnRH analogues, progesterone, and elagolix identified as the best approaches in reducing pain.
Our objective was to assess and rank different pharmacological interventions for relieving endometriosis-related pain. We conducted an online bibliographic search in different databases from their inception until March 2019. We included randomized controlled trials (RCTs) that assessed different medical therapies in the management of endometriosis-related pain. We applied this network meta-analysis (NMA) based on the frequentist approach using statistical package netmeta (version 1.0-1) in R software. Our main outcomes were the change in severity of pelvic pain, dysmenorrhea score, non-menstrual pelvic pain score, and dyspareunia score. Overall, 36 RCTs were included in this study (patients no. = 7942). Dienogest (0.94), combined hormonal contraceptives (CHCs) (0.782), and elagolix (0.38) were the highest-ranked interventions for reducing the severity of pelvic pain at three months, while at six months, gonadotropin-releasing hormone (GnRH) analogues (0.75), levonorgestrel-releasing intrauterine system (LNG-IUS) (0.73), and dienogest (0.65) were linked to more reduction in pelvic pain. The ranking p-score showed that GnRH analogues was the highest-ranked treatment for reducing dysmenorrhea at 3 months (1.00), while CHCs were the highest-ranked treatment at 6 months (0.97), followed by GnRH analogues (0.89). GnRH analogues (0.63) and elagolix (0.54) at three months while desogestrel (0.94) and CHCs (0.91) at six months were the highest-ranked treatment to reduce non-menstrual pelvic pain. GnRH analogues and elagolix were the highest-ranked pharmacologic therapies for reducing dyspareunia. In conclusion, CHCs, GnRH analogues, progesterone, and elagolix were the best approaches in reducing the pain of endometriosis. (C) 2020 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Endocrinology & Metabolism

Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis

Anas Zakarya Nourelden, Alaa Ahmed Elshanbary, Loalo'a El-Sherif, Amira Yasmine Benmelouka, Hagar Ismail Rohim, Sara Kamel Helmy, Merhan Kamal Sayed, Ammar Ismail, Ahmed Said Ali, Khaled Mohamed Ragab, Mohamed Sayed Zaazouee

Summary: Teplizumab is associated with lower insulin use and higher AUC of C-peptide in type 1 diabetic patients with no significant effect on Hb1c levels. However, teplizumab has shown some adverse effects such as lymphopenia and skin disorders.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2021)

Letter Obstetrics & Gynecology

Authors' Response: Can a Three-Arm RCT With Two Active Drugs Have One Placebo? Yes, the Literature Contains Many

Ahmed S. A. Ashour, Ahmed S. Ali

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Determining the Optimal Time Interval between Vaginal Dinoprostone Administration and Diagnostic Office Hysteroscopy in Nulliparous Women: A Randomized, Double-blind Trial

Nansy Mohamed Ali Rund, Hossam El Shenoufy, Bassem Aly Islam, Tarek El Husseiny, Salma Ashraf Nassar, Reham A. Mohsen, Doaa Alaa, Sherine H. Gad Allah, Ahmed Bakry, Rania Refaat, Mahmoud Ahmed Gehad, Mohamed Mahmoud Mohamed Kotb, Omneya M. Osman, Ahmed S. A. Ashour, Ahmed Said Ali, Ayman Taher, Khaled Kholaif, Ahmed T. Hashem, Ayman Aly Hamed Elsallamy, Dalia Adel Nour, Sherif Dahab, Bassem Talaat, Maged Almohammady

Summary: This study aimed to determine the optimal timing of vaginal dinoprostone administration before office hysteroscopy in nulliparous women. The results showed that administering dinoprostone vaginally 12 hours before the procedure was more effective in reducing pain during hysteroscopy compared to administering it 3 hours before. It also resulted in easier hysteroscope insertion, shorter procedure duration, and higher patient satisfaction.

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Castor oil for labor initiation in women with a previous cesarean section: a double-blind randomized study

Yomna Ali Bayoumi, Mahmoud Alalfy, Mohamed Sharkawy, Ahmed S. Ali, Hisham Mohamed Gouda, Dina Latif Hatem

Summary: The study found that castor oil can effectively initiate labor in women with a history of one previous cesarean section, increasing the rate of successful VBAC deliveries and providing a low-cost and harmless option to avoid ERCS.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Obstetrics & Gynecology

Comparative efficacy of lidocaine-prilocaine cream and vaginal misoprostol in reducing pain during levonorgestrel intrauterine device insertion in women delivered only by cesarean delivery: A randomized controlled trial

Ahmed T. Hashem, Mostafa Mahmoud, Bassem Aly Islam, Mohamed Ibrahem Eid, Nancy Ahmed, Ahmed Mohamed Mamdouh, Rasha Elkomy, Amira Fouad Elgamel, A. A. Ali Hamada, Eman M. Khalil, Ahmed S. A. Ashour, Ahmed Said Ali, Ayman Taher, Amr Hasan Hussein, Iman Elzahaby, Mohamed Hafez Mohamed Younes, Emad Salah, Eman M. Mojahed, Bassem Talaat, Mohamed ElHodiby, Nada Kamal Osman, Dalia Adel Nour, Yasser Khamis, Ayman Aly Hamed Elsallamy, Mahmoud Ahmed Gehad, Mohamed Mahmoud Mohamed Kotb, Sherine H. Gad Allah

Summary: In parous women delivered only by elective cesarean delivery, lidocaine-prilocaine cream and 200 micrograms of vaginal misoprostol effectively reduced pain during and 10 minutes after LNG-IUD insertion, with easier insertions, high patient satisfaction, and tolerable side effects.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2022)

Review Obstetrics & Gynecology

Preoperative Misoprostol to Reduce Blood Loss and Related Morbidities During Abdominal Hysterectomy: a Systematic Review and Meta-analysis of 10 Randomized Placebo-Controlled Trials

Ahmed Abu-Zaid, Yasmine Adel Mohammed, Saeed Baradwan, Reem Sayad, Esraa Faraag, Eman Reda Mohammed, Suhaila Mamdouh Mohammed, Ahmed Samy Ashour

Summary: This meta-analysis examined the efficacy and safety of preoperative misoprostol compared to placebo in abdominal hysterectomy. The results showed that misoprostol significantly reduced intraoperative blood loss, hemoglobin drop, and length of hospital stay compared to placebo. However, there were no significant differences between the two groups in operative time, rate of perioperative blood transfusion, and drug-related adverse events.

REPRODUCTIVE SCIENCES (2023)

Correction Peripheral Vascular Disease

Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis (vol 30, pg 207, 2023)

Amjaad Ibrahim Almarjan, Sara Abdulaziz Almarjan, Ahmed Taher Masoud

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2023)

Review Peripheral Vascular Disease

Different Doses of Scubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis

Amjaad Ibrahim Almarjan, Sara Abdulaziz Almarjan, Ahmed Taher Masoud

Summary: This study compares the efficacy and safety of sacubitril/valsartan with olmesartan in patients with hypertension. The results show that sacubitril/valsartan is more effective in lowering blood pressure and has a higher safety profile compared to olmesartan.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2023)

Review Obstetrics & Gynecology

Efficacy of lidocaine local anesthesia on pain perception during amniocentesis: A meta-analysis of randomized controlled trials

Ebraheem Albazee, Reem Sayad, Mohammad Alnifise, Abdulrahman Al-Anzi, Faisal Alshammari, Gheith Rasheed, Ahmed Samy, Haifa Al-Jundy, Marwah Ghazi Bintalib, Ahmed Abu-Zaid

Summary: This study evaluated the efficacy of lidocaine local analgesia in reducing maternal pain during amniocentesis. The results showed no significant difference in pain perception between the lidocaine group and the control group.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Obstetrics & Gynecology

Systematic review and meta-analysis of the efficacy of acupuncture as an adjunct to IVF cycles in China and the world

Ahmed Masoud, Fatma Elsayed, Ahmed Abu-Zaid, Greg Marchand, Rachel Lowe, Belle Liang, Manar Jallad

Summary: This study conducted a comprehensive analysis on the effectiveness and safety of acupuncture as an adjunct therapy to IVF cycles. The results showed that acupuncture had lower clinical and ongoing pregnancy rates in China compared to placebo, while outside of China acupuncture increased both clinical and ongoing pregnancy rates. The overall analysis did not show a statistically significant increase in clinical pregnancy rates worldwide when using acupuncture as an adjunct therapy to IVF.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Review Peripheral Vascular Disease

Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis

Shady Habboush, Ahmed Adel Sofy, Ahmed Taher Masoud, Omar Cherfaoui, Abdullah Mohamed Farhat, Ahmed Taha Abdelsattar, Ahmed Elmoursi

Summary: The aim of this study is to evaluate the efficacy of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled hypertension. Based on the analysis of six clinical trials, the triple therapy significantly reduces systolic and diastolic blood pressures, as well as 24-hour ambulatory blood pressure monitoring values.

HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2022)

Review Obstetrics & Gynecology

Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis Metforminin endometriyal karsinomlu kadinlarda proliferatif belirtecler uzerine etkisi: Sistematik derleme ve meta-analiz

Mohammad Abrar Shareef, Ahmed Adel Sofy, Ahmed Taha Abdelsattar, Ahmed Taher Masoud, Abdullah Mohamed Farhat, Hiba Maarouf

Summary: This systematic review and meta-analysis evaluated the efficacy of metformin in patients with endometrial carcinoma. The results demonstrate that metformin effectively reduces Ki-67 expression, as well as blood glucose and insulin levels.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

No Data Available